Metraipolis › archive › dc_cfa4898e32b2

Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries — Europe PMC PMID:41083250

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41083250
DOI
10.1111/vox.70131
License (as archived)
solo-consultazione
Archived
2026-11-09T09:21:58.085Z
SHA-256 of the archived text
6034eea1e2f1215db74755c8109032f00adb1e3ea033d91af0d93eec5fd9ff1b
Stable URL of this page
https://metraipolis.com/documento/dc_cfa4898e32b2

How to cite

Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries — Europe PMC PMID:41083250 — Europe PMC (en), https://europepmc.org/article/MED/41083250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfa4898e32b2 (Metraipolis archive dc_cfa4898e32b2, sha256 6034eea1e2f1215db74755c8109032f00adb1e3ea033d91af0d93eec5fd9ff1b)
BibTeX
@misc{dccfa4898e32b2,
  title = {Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries — Europe PMC PMID:41083250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41083250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfa4898e32b2; sha256 6034eea1e2f1215db74755c8109032f00adb1e3ea033d91af0d93eec5fd9ff1b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41083250. Agents can read the archived copy with the MCP tool read_document.